258 related articles for article (PubMed ID: 30266820)
1. NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands.
Zhao X; Weinhold S; Brands J; Hejazi M; Degistirici Ö; Kögler G; Meisel R; Uhrberg M
Blood Adv; 2018 Oct; 2(19):2452-2461. PubMed ID: 30266820
[TBL] [Abstract][Full Text] [Related]
2. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
3. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
Front Immunol; 2020; 11():561553. PubMed ID: 33178188
[TBL] [Abstract][Full Text] [Related]
4. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
[TBL] [Abstract][Full Text] [Related]
5. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I.
Schönberg K; Fischer JC; Kögler G; Uhrberg M
Blood; 2011 May; 117(19):5152-6. PubMed ID: 21415265
[TBL] [Abstract][Full Text] [Related]
6. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
7. [KIRs on human NK cells and in relation with HLA class I antigen--review].
Dou LP; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):627-30. PubMed ID: 16800958
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
[TBL] [Abstract][Full Text] [Related]
9. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.
Andersson S; Fauriat C; Malmberg JA; Ljunggren HG; Malmberg KJ
Blood; 2009 Jul; 114(1):95-104. PubMed ID: 19304956
[TBL] [Abstract][Full Text] [Related]
10. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
11. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia.
Nguyen MAT; Hosokawa K; Yoroidaka T; Maruyama H; Espinoza JL; Elbadry MI; Mohiuddin M; Tanabe M; Katagiri T; Nakagawa N; Chonabayashi K; Yoshida Y; Arima N; Kashiwase K; Saji H; Ogawa S; Nakao S
Immunohorizons; 2020 Jul; 4(7):430-441. PubMed ID: 32680908
[TBL] [Abstract][Full Text] [Related]
12. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
13. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
[TBL] [Abstract][Full Text] [Related]
14. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
15. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
[TBL] [Abstract][Full Text] [Related]
16. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
[TBL] [Abstract][Full Text] [Related]
17. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.
Becker S; Tonn T; Füssel T; Uhrberg M; Bogdanow M; Seifried E; Seidl C
Hum Immunol; 2003 Feb; 64(2):183-93. PubMed ID: 12559621
[TBL] [Abstract][Full Text] [Related]
18. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
20. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.
Björkström NK; Béziat V; Cichocki F; Liu LL; Levine J; Larsson S; Koup RA; Anderson SK; Ljunggren HG; Malmberg KJ
Blood; 2012 Oct; 120(17):3455-65. PubMed ID: 22968455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
